If you have encountered an injury to the knee meniscus, knee cartilage, ACL or MCL ligaments, or have chronic knee pain due to a past injury or arthritis, you may be a good candidate for knee stem cell therapy or blood platelet procedures. Traditional options for patients suffering from these issues include arthroscopic knee surgery to repair ligament tears, or total knee joint replacement. With both surgeries, months of rehab are required to regain strength and mobility, and the patient must be aware of and prepared to take on the risks.
As an alternative to knee surgery or knee replacement, Regenexx procedures may help alleviate knee pain and the conditions that cause it with a same-day office injection procedure. Unlike traditional surgery, Regenexx patients are typically encouraged to walk the same day, and most patients experience very little down time from the procedure.
Commonly Treated Knee Conditions - Regenexx Stem Cell and Platelet Procedures
Commonly Treated Knee Conditions
This is not a complete list of conditions treated, but the most common knee conditions we have treated throughout the years. If you are experiencing knee pain, injury, or arthritis, please contact us or complete the candidacy form below to learn more about whether the Regenexx Procedures are right for you.
- Patellofemoral Syndrome/Chondomalacia
- Pes anersine bursitis
- Baker’s cyst
- Patellar tendonitis
- Meniscus tear
- MCL sprain or tear
- ACL sprain or tear
- PCL sprain or tear
- LCL sprain or tear
- Biceps Femoris Insertional Tendinopathy
- Hamstrings Tendinopathy
Dr. John Pitts Discusses Common Knee Injuries and Treatments
Regenexx Knee Patient Outcome Data
Knee Patient Outcome Data
This Regenexx-SD (same-day) bone marrow derived stem cell treatment outcome data analysis is part of the Regenexx data download of patients who were tracked in the Regenexx advanced patient registry.View Knee Patient Outcome Data Here
Knee Meniscus Procedure Outcome Data
This Regenexx-SD (same-day) bone marrow derived stem cell treatment outcome data analysis is part of the Regenexx data download of patients who were tracked in the Regenexx advanced patient registry following treatment for Meniscus Tears.View Knee Meniscus Procedure Outcome Data Here
Knee Function Improvement Data
This data utilizes LEFS (Lower Extremity Functional Scale) data from our knee arthritis patients treated with stem cell injections. Functional questionnaires ask the patients questions such as how well they can walk, run, climb stairs, etc. The improvements following the Regenexx-SD procedure are highly statistically significant.View Knee Function Improvement Data Here
Interested in Joint Replacement vs Stem Cell Procedure Data?
If you are considering a knee replacement, you might want to read about how stem cells stack up against knee replacements.
Recently Published Research on Regenexx Stem Cell Procedure for Knee Osteoarthritis
Introduction. We investigated the use of autologous bone marrow concentrate (BMC) with and without an adipose graft, for treatment of knee osteoarthritis (OA). Methods. Treatment registry data for patients who underwent BMC procedures with and without an adipose graft were analyzed. Pre- and posttreatment outcomes of interest included the lower extremity functional scale (LEFS), the numerical pain scale (NPS), and a subjective percentage improvement rating. Multivariate analyses were performed to examine the effects of treatment type adjusting for potential confounding factors. The frequency and type of adverse events (AE) were also examined. Results. 840 procedures were performed, 616 without and 224 with adipose graft. The mean LEFS score increased by 7.9 and 9.8 in the two groups (out of 80), respectively, and the mean NPS score decreased from 4 to 2.6 and from 4.3 to 3 in the two groups, respectively. AE rates were 6% and 8.9% in the two groups, respectively. Although pre- and posttreatment improvements were statistically significant, the differences between the groups were not. Conclusion. BMC injections for knee OA showed encouraging outcomes and a low rate of AEs. Addition of an adipose graft to the BMC did not provide a detectible benefit over BMC alone.
The Regenexx Difference
Regenexx Stem Cell Procedures Televised to Millions Across U.S.
The episode features Dr. Centeno and Dr. Hanson, along with patient Barbee James, who required stem cell treatment after a failed micro fracture and continued problems following traditional knee surgery. The episode provided a nice overview of a Regenexx-SD (same-day) stem cell procedure for Barbee’s knee cartilage damage.
On February 28, 2013 Seattle King TV featured Regenexx patient Paul Lyon, who underwent a Regenexx-SD knee procedure in our Broomfield clinic. The story looks at his results and includes an interview with Dr. Christopher Centeno, along with footage in our advanced lab where stem cells are processed as part of the procedure.
Are You a Candidate For Stem Cell Treatment of Your Knee Pain?
If you are interested in learning whether you are a good candidate for the Regenexx Procedure, please complete the Regenexx Procedure Candidate Form below or call us at 888-525-3005.